Ghrelin
In clinical developmentAlso known as Ghrelin (human), Ghrelin human, Human ghrelin, Lenomorelin.
Recent clinical, regulatory, research and industry developments relating to this drug.
Unacylated Ghrelin to Improve Functioning in PAD: The GIFT Trial Phase II
The Effects of Ghrelin Administration on Motivation and Resting Energy Expenditure
Will Work for Reward: Effects of Ghrelin Administration on Dopamine and Effort
Ghrelin (OXE--103) for Acute Concussion Management
Effect of Ghrelin on Glucose Metabolism After Bariatric Surgery
Effect of Ghrelin on Nutritional and Financial Decision-Making
Caloric restriction in female reproduction: is it beneficial or detrimental?
Ghrelin Plus Strength Training in Frail Elderly Study
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Ghrelin (OXE--103) for Acute Concussion Management
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- The Journal of clinical investigation2
- Addiction biology1
- American journal of physiology. Cell physiology1
- Biological psychiatry1
- Diabetes1
- Nature communications1
- Cummings DE2
- Horvath TL2
- Leggio L2
- Shanabrough M2
- Abizaid A1
- Andrews ZB1
- Austin D1
- Bagriantsev SN1
- Yale University School of Medicine2
- Basic Medical College1
- Basque Foundation for Science1
- Carle Foundation Hospital1
- Carle Illinois College of Medicine1
- Center for Alcohol and Addiction Studies1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 5 of the same disease areas as Ghrelin in the shared literature.
Studied across 2 of the same disease areas as Ghrelin in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials